Similarly, the percentages of tumour-infiltrating CD3+CD27+ cells were significantly lower post-FLOT chemotherapy compared to the treatment-naïve setting (16.1 ± 2.7 vs. 5.41 ± 2.6%, p = 0.01), (Fig. 5). This evidence concerns the gene CD27 and neoplasm.